Literature DB >> 28375702

Beyond Antibodies as Binding Partners: The Role of Antibody Mimetics in Bioanalysis.

Xiaowen Yu1, Yu-Ping Yang1, Emre Dikici1, Sapna K Deo1, Sylvia Daunert1.   

Abstract

The emergence of novel binding proteins or antibody mimetics capable of binding to ligand analytes in a manner analogous to that of the antigen-antibody interaction has spurred increased interest in the biotechnology and bioanalytical communities. The goal is to produce antibody mimetics designed to outperform antibodies with regard to binding affinities, cellular and tumor penetration, large-scale production, and temperature and pH stability. The generation of antibody mimetics with tailored characteristics involves the identification of a naturally occurring protein scaffold as a template that binds to a desired ligand. This scaffold is then engineered to create a superior binder by first creating a library that is then subjected to a series of selection steps. Antibody mimetics have been successfully used in the development of binding assays for the detection of analytes in biological samples, as well as in separation methods, cancer therapy, targeted drug delivery, and in vivo imaging. This review describes recent advances in the field of antibody mimetics and their applications in bioanalytical chemistry, specifically in diagnostics and other analytical methods.

Entities:  

Keywords:  antibodies; antibody mimetics; biosensors; diagnostics; molecular imaging; protein scaffolds

Mesh:

Substances:

Year:  2017        PMID: 28375702      PMCID: PMC5895458          DOI: 10.1146/annurev-anchem-061516-045205

Source DB:  PubMed          Journal:  Annu Rev Anal Chem (Palo Alto Calif)        ISSN: 1936-1327            Impact factor:   10.745


  151 in total

1.  Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and taq DNA polymerase.

Authors:  K Nord; E Gunneriusson; M Uhlén; P A Nygren
Journal:  J Biotechnol       Date:  2000-06-09       Impact factor: 3.307

Review 2.  Generation of bioreagents for protein chips.

Authors:  Michael L Phelan; Steffen Nock
Journal:  Proteomics       Date:  2003-11       Impact factor: 3.984

3.  Crystal structure of Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in complex with trypsin. Implications for KD1 specificity of inhibition.

Authors:  Amy E Schmidt; Hitendra S Chand; Dulio Cascio; Walter Kisiel; S Paul Bajaj
Journal:  J Biol Chem       Date:  2005-06-02       Impact factor: 5.157

Review 4.  Engineered protein scaffolds as next-generation antibody therapeutics.

Authors:  Michaela Gebauer; Arne Skerra
Journal:  Curr Opin Chem Biol       Date:  2009-06-06       Impact factor: 8.822

5.  Structure-function studies of an engineered scaffold protein derived from Stefin A. II: Development and applications of the SQT variant.

Authors:  Lukas Kurt Josef Stadler; Toni Hoffmann; Darren Charles Tomlinson; Qifeng Song; Tracy Lee; Michael Busby; Yvonne Nyathi; Elisenda Gendra; Christian Tiede; Keith Flanagan; Simon J Cockell; Anil Wipat; Colin Harwood; Simon D Wagner; Margaret A Knowles; Jason J Davis; Neil Keegan; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2011-05-25       Impact factor: 1.650

6.  Tumor-targeting antibody-anticalin fusion proteins for in vivo pretargeting applications.

Authors:  Martina Steiner; Katrin Gutbrodt; Nikolaus Krall; Dario Neri
Journal:  Bioconjug Chem       Date:  2013-02-06       Impact factor: 4.774

7.  Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2.

Authors:  A Régina; M Demeule; C Ché; I Lavallée; J Poirier; R Gabathuler; R Béliveau; J-P Castaigne
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

8.  Asteropsins B-D, sponge-derived knottins with potential utility as a novel scaffold for oral peptide drugs.

Authors:  Huayue Li; John J Bowling; Mingzhi Su; Jongki Hong; Bong-Jin Lee; Mark T Hamann; Jee H Jung
Journal:  Biochim Biophys Acta       Date:  2013-11-10

9.  A system for the continuous directed evolution of biomolecules.

Authors:  Kevin M Esvelt; Jacob C Carlson; David R Liu
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

Review 10.  Miniproteins as phage display-scaffolds for clinical applications.

Authors:  Frederic Zoller; Uwe Haberkorn; Walter Mier
Journal:  Molecules       Date:  2011-03-14       Impact factor: 4.411

View more
  16 in total

1.  Identification of pathogenic bacteria in human blood using IgG-modified Fe3O4 magnetic beads as a sorbent and MALDI-TOF MS for profiling.

Authors:  Jia Yi; Qin Qin; Yan Wang; Rutan Zhang; Hongyan Bi; Shaoning Yu; Baohong Liu; Liang Qiao
Journal:  Mikrochim Acta       Date:  2018-11-10       Impact factor: 5.833

2.  Spatial Sequencing: A Perspective.

Authors:  Brian M Turczyk; Michele Busby; Allison L Martin; Evan R Daugharthy; Daniel Myung; Richard C Terry; Samuel A Inverso; Richie E Kohman; George M Church
Journal:  J Biomol Tech       Date:  2020-07

Review 3.  Potential of Phage Display Antibody Technology for Cardiovascular Disease Immunotherapy.

Authors:  Soo Ghee Yeoh; Jia Siang Sum; Jing Yi Lai; W Y Haniff W Isa; Theam Soon Lim
Journal:  J Cardiovasc Transl Res       Date:  2021-08-31       Impact factor: 3.216

Review 4.  Protein scaffolds: antibody alternatives for cancer diagnosis and therapy.

Authors:  Renli Luo; Hongguang Liu; Zhen Cheng
Journal:  RSC Chem Biol       Date:  2022-05-25

5.  The mosaic puzzle of the therapeutic monoclonal antibodies and antibody fragments - A modular transition from full-length immunoglobulins to antibody mimetics.

Authors:  Sami El Khatib; Mohamed Salla
Journal:  Leuk Res Rep       Date:  2022-06-27

6.  Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review.

Authors:  Vincent Q Sier; Joost R van der Vorst; Paul H A Quax; Margreet R de Vries; Elham Zonoobi; Alexander L Vahrmeijer; Ilona A Dekkers; Lioe-Fee de Geus-Oei; Anke M Smits; Weibo Cai; Cornelis F M Sier; Marie José T H Goumans; Lukas J A C Hawinkels
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 7.  Miniproteins as a Powerful Modality in Drug Development.

Authors:  Zachary R Crook; Natalie W Nairn; James M Olson
Journal:  Trends Biochem Sci       Date:  2020-01-31       Impact factor: 14.264

Review 8.  Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Authors:  Michael R Pranzatelli
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

9.  A Two-Step Approach for the Design and Generation of Nanobodies.

Authors:  Hanna J Wagner; Sarah Wehrle; Etienne Weiss; Marco Cavallari; Wilfried Weber
Journal:  Int J Mol Sci       Date:  2018-11-02       Impact factor: 5.923

10.  The reduced form of the antibody CH2 domain.

Authors:  Zhaoyong Xi; Xianglei Liu; Rui Lin; John D Persons; Tatiana V Ilina; Wei Li; Dimiter S Dimitrov; Rieko Ishima
Journal:  Protein Sci       Date:  2021-06-16       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.